Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve Unaudited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenotech Laboratories has informed BSE that its Board of Directors will meet on Friday, January 23, 2026, to consider and approve the Unaudited Standalone Financial Results for the quarter and nine months ended December 31, 2025. This is a routine advance intimation filed under SEBI Listing Regulations. The company has also closed its trading window from January 1, 2026 until January 25, 2026, which is standard practice around results declaration. No actual financial numbers have been disclosed in this filing.
Investors should wait for the actual results on or after January 23, 2026 for any meaningful impact. The trading window closure means insiders cannot trade in the stock until 48 hours after results are declared, which is normal and not a negative signal on its own.